A study combining PD-L1 and CTLA-4 blockade showed that most TRAEs in HBV+ HCC were dermatological signs and elevated laboratory indices for liver function, including pruritus, rash, increased ALT level, and increased AST level (66). This evidence concerns the gene GPT and hepatocellular carcinoma.